Board of Directors



John S. Patton, Ph.D.
Member, Board of Directors

Dr. Patton is CEO and Co-Founder of Dance Pharmaceuticals.  A biotechnologist and serial entrepreneur, prior to founding Dance and co-founding InCarda Therapeutics he was co-founder of Inhale Therapeutics (now Nektar), where he served as a Director, Head of Research and Chief Scientific Officer from 1990-2008. Before that he led the drug delivery group at Genentech (1985-1990). At Inhale/Nektar he helped lead the development and FDA approval of the first inhaled insulin product and is considered to be the "father of inhaled insulin".  At Inhale/Nektar, Dr. Patton participated in multiple financings totaling >$700M over 15 years and was a key driver for most of the important business development deals done by the company.

Prior to joining Genentech, Dr. Patton was a tenured professor at the University of Georgia. He serves on scientific advisory boards for Penn State University, Scripps Institution of Oceanography, Next Safety and Aridis Pharmaceuticals as well as on the executive boards of Halozyme, Activaero, and InCarda Therapeutics. He is author or coauthor of >100 publications and inventor or coinventor of >37 patents.

Dr. Patton received his Ph.D. in biology from the University of California, San Diego and held post-doctoral positions in biomedicine at Harvard Medical School and the University of Lund, Sweden.